HOME / NEWS

Press releases

Glycorex Transplantation (GTAB B): Enters distribution agreement in Greece for Glycosorb® ABO in the field of transfusion and transplantation

February 28, 2025, 9:06 am | Non-regulatory
Read more

Glycorex Transplantation AB: First ABO-incompatible transplantation in Portugal with Glycosorb® ABO

February 18, 2025, 3:26 pm | Non-regulatory
Read more

Glycorex Transplantation AB (GTAB B): First blood group-incompatible pediatric heart transplantation in Austria using Glycosorb® ABO

December 23, 2024, 8:30 am | Non-regulatory
Read more

Glycorex Transplantation AB (GTAB B): Results from Norwegian platelet evaluation presented at conference

September 13, 2024, 11:15 am | Non-regulatory
Read more

Glycorex Transplantation AB: First ABO-incompatible transplantation in Argentina with Glycosorb® ABO

August 13, 2024, 10:00 am | Non-regulatory
Read more

Glycosorb® ABO is pushing the boundaries in paediatric blood group incompatible heart transplantation

May 13, 2024, 8:20 am | Non-regulatory
Read more

First publication from South Africa and first stem cell transplantation performed in Mexico

May 8, 2024, 1:24 pm | Non-regulatory
Read more

Glycorex Transplantation (GTAB B): Signs agreement with distributor in Romania

February 20, 2024, 12:39 pm | Non-regulatory
Read more

Glycorex Transplantation AB: Entering into an agreement with Bio-Rad Laboratories, Inc.

November 29, 2023, 10:31 am | Regulatory
Read more

Glycorex Transplantation AB (publ): Interim Report January – September 2023

November 29, 2023, 8:00 am | Regulatory
Read more

Glycorex Transplantation AB (publ): Interim Report January – June 2023

August 30, 2023, 8:00 am | Regulatory
Read more

Glycorex appoints Lars Juliusson as Business Development Manager Transfusion

August 14, 2023, 3:00 pm | Non-regulatory
Read more

Subscribe to our releases

Choose categories Year-end report Interim report Annual report Press release Invitation Newsletter

Contact information Name E-mail SMS (ex. +46709123456)

The subscription service is provided by Cision.se and your information will be stored on their servers. The information will only be used to send you notifications when new releases are published. No personal information will be shared with any outside parties. Read more about our Privacy Policy.

News/Presentations

Johan Lavén, CEO presenting Glycorex Transplantation on Aktiedagen (Aktiespararna) September 19 2023.

The presentation on Youtube >>

Geert Nygaard, CEO presenting Glycorex Transplantation on Aktiedagen (Aktiespararna) januari 31 2022.

The presentation on Youtube >>

Pontus Nobréus, CEO presenting Glycorex Transplantation on Redeye Growth Day june 2.
Presentationen >>

Download the presentationen >>

Pontus Nobréus, CEO presenting Glycorex Transplantation BioStock Life Science Spring Summit on May 26
https://youtu.be/5fpTsNENiO8

Download the presentation >>

Glycorex Transplantation is a proud collaborator with The Hospital Clínic de Barcelona in Spain. It recently became the first hospital in Spain to carry out more than 1,000 living donor kidney transplants. To celebrate this milestone, a campaign called “A thousand transplants, a thousand stories” was launched to increase public awareness and encourage living donor kidney donations. https://www.clinicbarcelona.org/en/news/the-hospital-clinic-the-first-hospital-in-spain-to-carry-out-1-000-living-donor-kidney-transplants

REDEYE GROWTH DAY
Pontus Nobréus, CEO of Glycorex Transplantation will present at the Redeye Growth Day on June 2, 2021 at 08:50 CET.
Link to live streaming: https://www.redeye.se/events/808637/redeye-growth-day-2021

Glycorex Transplantation participates in the BioStock Life Science Spring Summit 2021. CEO Pontus Nobréus will present the company at the BioStock Life Science Spring Summit on May 26-27. For more information please visit: www.summit.biostock.se

Scheelevägen 27 | SE-223 63 Lund, Sweden

Phone: +46 46 286 52 30 | Fax: +46 46-286 52 39
E-mail: info@glycorex.com

Org.nr: 556519-7372

Glycorex Privacy Policy (GDPR) »